Slovakia Fines Medical Laboratories €14.5 Million for Price-Fixing Cartel

Slovakia's Antimonopoly Office imposed fines totaling €14.5 million on four major medical laboratories for operating an illegal price-fixing cartel. The penalties followed a three-year investigation that began after Adam Marek, an analyst at the Value for Money Unit within the Finance Ministry, uncovered evidence of coordinated pricing practices among the laboratories. Marek, who specializes in healthcare analysis, discovered that the laboratories maintained artificially high profit margins through their cartel arrangement. The Value for Money Unit is a government body that analyzes public spending efficiency and identifies potential irregularities in various sectors, including healthcare. The Antimonopoly Office, Slovakia's competition authority, has the power to investigate and penalize companies that engage in anti-competitive practices such as price-fixing or market manipulation. The case highlights broader concerns about cartel behavior in Slovakia's healthcare sector, where coordination among service providers can drive up costs for both patients and the public health insurance system. The substantial fines represent one of the larger competition enforcement actions in the country's medical services industry.